Schonfeld Strategic Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,275
Closed -$449K 2279
2024
Q2
$449K Sell
10,275
-2,035
-17% -$98.3K ﹤0.01% 1531
2024
Q1
$587K Buy
+12,310
New +$553K ﹤0.01% 1419
2020
Q4
Sell
-5,400
Closed -$267K 1770
2020
Q3
$267K Buy
5,400
+600
+13% +$33.9K 0.01% 1129
2020
Q2
$253K Buy
+4,800
New +$228K 0.01% 1048
2020
Q1
Sell
-5,300
Closed -$463K 1386
2019
Q4
$463K Buy
5,300
+1,400
+36% +$122K 0.01% 775
2019
Q3
$331K Buy
+3,900
New +$347K 0.01% 758
2019
Q2
Sell
-4,879
Closed -$516K 1167
2019
Q1
$516K Buy
+4,879
New +$490K 0.02% 682
2018
Q1
Sell
-4,671
Closed -$329K 912
2017
Q4
$329K Buy
+4,671
New +$337K 0.03% 561

Other funds holding NGVT

Schonfeld Strategic Advisors's NGVT Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of Ingevity (NGVT) in Q3 2024, closing a stake of 10,275 shares — an estimated $449K sold.

Schonfeld Strategic Advisors first reported a position in NGVT in Q4 2017 and held it in 8 quarters. The position peaked at $587K in Q1 2024. 261 funds tracked by Wall St. Rank hold NGVT as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining Ingevity position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 10,275 Ingevity shares in Q3 2024, an estimated $449K.
  • Schonfeld Strategic Advisors first reported a position in Ingevity in Q4 2017 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's Ingevity position peaked at $587K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held Ingevity as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.